A randomised controlled trial of fluid restriction compared to oesophageal Doppler-guided goal-directed fluid therapy in elective major colorectal surgery within an Enhanced Recovery After Surgery program SUMMARY There is continued controversy regarding the benefits of goal-directed fluid therapy, with earlier studies showing marked improvement in morbidity and length-of-stay that have not been replicated more recently. The aim of this study was to compare patient outcomes in elective colorectal surgery patients having goaldirected versus restrictive fluid therapy. Inclusion criteria included suitability for an Enhanced Recovery After Surgery care pathway and patients with an American Society of Anesthesiologists Physical Status score of 1 to 3. Patients were intraoperatively randomised to either restrictive or Doppler-guided goal-directed fluid therapy. The primary outcome was length-of-stay; secondary outcomes included complication rate, change in haemodynamic variables and fluid volumes. One hundred patients, 50 in each group, were included in the analysis. Compared to restrictive therapy, goal-directed therapy resulted in a greater volume of intraoperative fluid, 2115 (interquartile range 1350 to 2560) ml versus 1500 (1200 to 2000) ml, P=0.008, and was associated with an increase in Doppler-derived stroke volume index from beginning to end of surgery, 43.7 (16.3) to 54.2 (21.1) ml/m 2 , P <0.001, in the latter group. Length-ofstay was similar, , P=0.421. The number of patients with any complication (minor or major) was similar; 60% (30) versus 52% (26), P=0.42, or major complications, 1 (2%) versus 4 (8%), P=0.36, respectively. The increased perioperative fluid volumes and increased stroke volumes at the end of surgery in patients receiving goal-directed therapy did not translate to a significant difference in length-of-stay and we did not observe a difference in the number of patients experiencing minor or major complications.
There is continued controversy regarding the benefits of goal-directed fluid therapy (GDT) which requires the use of a cardiac output monitor such as the oesophageal Doppler monitor. Previous evidence of improved outcome from GDT in colorectal surgery led to a recommendation from national bodies in the United Kingdom and United States to endorse Doppler-guided GDT as a standard of care in major abdominal surgery, including colectomies 1 . Its use has also been supported within an Enhanced Recovery After Surgery (ERAS) program for colonic resection 2 . However, these earlier studies did not compare GDT directly with fluid restriction, which had also shown improvements in patient outcomes [3] [4] [5] . Recently, two studies have compared fluid restriction to GDT in major colorectal surgery and found no significant difference in outcome between the two techniques 6, 7 . However, there is a much larger body of work supporting GDT, with a total of 32 studies and 2808 patients in a recent review, which found a reduction in mortality and morbidity in high-risk surgery and in morbidity alone in low-risk surgery (identified as a mortality rate <5%) 8 . There is also a spectrum of GDT protocols with some using fluid therapy alone as the intervention, while others use fluid and inotropes, such as dopexamine, to achieve an oxygen delivery target. Given that both approaches led to a reduction in complication rates in a recent review 8 , a Doppler-guided, fluid-only algorithm would be more practical within an ERAS framework where the use of inotropes requiring central lines and critical care admissions would not be practical. The aim of our study thus was to compare outcomes in elective colorectal surgery between patients having restrictive versus Dopplerguided GDT.
MATERIALS AND METHODS
This was a prospective blinded study at the St Vincent's Hospital campus, St Vincent's Public Hospital and St Vincent's Private Hospital, Fitzroy, Victoria. The study had institutional ethics approval (no. 039/12) and was registered with the Australia and New Zealand Clinical Trials Registry, ACTRN12612000717853.
Enrolment
All patients undergoing major colorectal surgery and enrolled in the local ERAS care pathway were screened for eligibility.
Exclusion criteria included American Society of Anesthesiologists Physical Status 4, pregnancy, inability to give informed consent, emergency surgery, significant renal dysfunction (estimated glomerular filtration rate <50 ml/minute), hepatic dysfunction, severe heart failure (New York Heart Association classification 3 or 4), age <18 years and oesophageal pathology (such as varices), which is a relative contraindication to an oesophageal probe.
Randomisation with sealed opaque envelopes was through a computer-generated randomisation sequence and occurred on the day of surgery just prior to the anaesthetic. Randomisation was stratified to either stoma or non-stomal pathway to ensure equal numbers in each group. Colorectal resections that require a stoma have a separate ERAS pathway to allow for patient education about stomal care. In addition, stomas are more frequently utilised in lower rectal resections which are associated with increased length-of-stay (LOS) and have a higher anastomosis leakage rate 9, 10 . The anaesthetist was not blinded. However, the patient, surgical team and data collectors were.
The patients followed an ERAS clinical care pathway. Patients did not have routine nasogastric tube insertion. Oral fluids were encouraged four hours post-surgery and oral diet commenced from day one. Discharge criteria included resumption of normal diet without nausea or vomiting, return of bowel function, ability to self-care and mobilise independently or be able to be cared for and mobilised by pre-existing care arrangements. Pain needed to be adequately controlled with oral analgesics.
Treatment
All patients had a general anaesthetic technique with muscle relaxant. This consisted of a balanced anaesthetic induction including midazolam, a short acting opioid, propofol and a muscle relaxant. Maintenance was with an inhalational agent (sevoflurane or desflurane). Total intravenous anaesthesia was used if indicated. Epidural analgesia was utilised for planned open surgery if there were no contraindications. Transversus abdominal plane blocks were also utilised where appropriate. Intraoperatively, all patients were given intravenous paracetamol and parecoxib unless there was a contraindication. The postoperative analgesia protocol consisted of regular paracetamol, non-steroidal anti-inflammatory drugs and opioid patient-controlled analgesia.
Fluid therapy followed a strict protocol with the restrictive group receiving a set maintenance rate ( Table 1 ). The oesophageal Doppler monitor (ODM) was not used in this group. Previous work has already established that GDT using ODM results in improved stroke volume (SV) and a reduction in corrected flow time compared to a restrictive fluid policy 6, 7 . The GDT group had a similar protocol except during the time of the intraoperative intervention an ODM was utilised to facilitate targeting colloid boluses to fluid responsiveness as indicated by a change in SV index (SVI) >10% and a corrected flow time interval of <350 milliseconds 11 . Anaesthetists in the intervention group were asked to adhere to the SV optimisation algorithm (Figure 1 ), which stipulates the administration of a 250 ml bolus of a colloid, although the colloid type was at the discretion of the anaesthetist. This was due to a lack of evidence of efficacy of one type of fluid over another 12 , although colloids were encouraged as they generally result in greater intravascular expansion 13 The ODM was inserted only in the GDT group, with the position and settings optimised for maximal velocity time signal 11 . The ODM was inserted by the anaesthetist. Readings at the beginning and end of surgery were taken. A locally-adapted postoperative nausea and vomiting guideline was used, based on consensus guidelines 15 .
Data collection.
All postoperative data were collected by a research nurse or research registrar who was blinded to the allocation. The Clavien-Dindo complications classification system was used to categorise complications by type and grade 16 . Patients were followed up either by phone call or outpatient appointment to determine 30-day mortality and readmission.
Statistics
Power analysis was based on the primary outcome-LOS. With an LOS of eight days (standard deviation 3.5), based on previous local data for colectomies, we estimated that GDT would reduce this by two days, based on earlier studies 17 . The estimated sample size was 98 (α=0.05, power=0.80). This was increased to 100 to allow for dropouts and exclusions.
Secondary outcomes included number of patients suffering any complication, number of patients suffering from major complications (Clavien-Dindo grade 3 or higher), intravenous fluid volumes administered to patients and change in patients' haemodynamic parameters.
Continuous data were assessed with Student's t-test, with graphical and quantitative testing for normality (Shapiro-Wilk test). Non-parametric data were assessed with the Mann-Whitney U test. Haemodynamic parameters were assessed with a paired t-test. Dichotomous data were assessed using chi-square statistics or Fisher's exact tests for smaller events (<5) and ranked data were assessed with Spearman's test for univariable comparisons. All statistical analysis was performed using Stata 12.1 (StataCorp LP, College Station, TX, USA).
RESULTS
We consecutively screened all patients eligible for the ERAS protocol from June 2012 to December 2013. A consort diagram illustrates the flow of patients ( Figure 2 ). Of 131 eligible patients, 100 patients consented and were studied. Six refused consent, one did not have an investigator available and 24 did not meet the inclusion criteria. All randomised patients were studied and included in the analysis as intention to treat. There was no loss to follow-up. Demographic characteristics and surgical data for included patients are summarised in Table 2 .
There was a laparoscopic surgery rate of 56% for restrictive therapy and 62% for GDT, both consistent with the high proportion of laparoscopic work in this unit. There was also a high proportion of patients (22%) who had inflammatory bowel disease. Stratification ensured equal numbers of each group in the stomal and no stoma pathway.
Fluid volumes were categorised by type and period of administration (Table 3 ). Compared to the restrictive group, the GDT group had more fluid boluses (121 versus 48), a higher volume of intraoperative colloid (500 [250 to 750] versus 0 [0 to 300] ml, P=0.012) and an overall increased cumulative fluid volume at the end of postoperative day two, (5061 [3860 to 6881] versus 3863 [3132 to 5628] ml, P=0.016).
Standard haemodynamic data for both the restrictive and GDT groups are displayed in Table 4 . Doppler parameters at the start and end of surgery are displayed for the Doppler-guided GDT group The primary outcome, LOS, was similar between the two groups, with the restrictive group median of 6 (4 to 9) versus the GDT median of 6.5 (5 to 9), P=0.421 (Table 5 ). Medically ready for discharge LOS ( Table 5 ) was also estimated to account for when patients had met predefined ERAS discharge criteria-this allows separation between medical and non-medical reasons for a delayed hospital discharge.
Complications were the secondary outcome and did not show a significant difference in terms of the proportion of patients suffering any complication (52% [26 patients] versus 60% [30 patients]) ( Table  5 ). The proportion who had major complications (Clavien-Dindo grade 3 to 5) was also not statist-ically different (restrictive 8% [four patients] versus GDT 2% [one patient]). The count of major complications, which reflects more than one complication in some patients, showed a larger number of major complications in the restrictive group (nine versus one, P=0.007) ( Table 6 ). There was one death in the restrictive group. This patient had a laparoscopic ultra-low anterior resection with ileostomy and had an uneventful immediate postoperative course until day three, when he developed nausea and vomiting and later had a cardiorespiratory arrest. There were no deaths in the GDT group (the study was not adequately powered to assess these secondary outcomes, so no firm conclusions can be drawn here).
DISCUSSION
ERAS programs incorporate specific intraoperative and postoperative fluid regimens that have been identified as key components for successful implementation 18 . There are differing fluid therapy protocols that have been used within ERAS. In the study by Muller et al, fluid restriction had been used. However, there is some evidence that suggests fluid restriction may increase morbidity in major abdominal surgery. Holte et al found a trend towards increased complications in a restrictive fluid therapy group and called for further studies looking at fluid optimisation using GDT 19 . Futier et al found that GDT with restriction increased morbidity compared to GDT with liberal fluid therapy 20 . Zakhaleva et al compared Doppler-guided GDT with a liberal fluid therapy in 91 patients and found a significant difference in complication rate in favour of GDT (22% versus 49%, P=0.022), although this did not result in an improvement in LOS 21 . In contrast, two recent studies found no significant difference when GDT was compared to fluid restriction alone 6, 7 .
Our hypothesis was that GDT would confer an advantage compared to fluid restriction alone within an ERAS clinical care pathway. This is one of the few studies that has included a significant number of low rectal resections with stoma, which are associated with greater morbidity and increased LOS 9 . We have sought to be comprehensive in reporting of all complications, including minor complications that may impair recovery but were not collected in earlier studies 7 .
The GDT group had an increased SVI and systolic flow time by the end of surgery. Additionally, GDT patients received a greater frequency of fluid boluses (121 versus 48), which would be consistent with successful implementation of a GDT algorithm. Importantly, the GDT optimisation of intraoperative haemodynamics was achieved within a framework of overall fluid restriction. Both the restrictive and GDT groups in our study would fit within the definition of 'restrictive' suggested by Rahbari et al with low intraoperative and perioperative fluid totals 22 . This is in contrast to a study by Challand et al, where a mean volume of 5339 ml 23 (compared to 2190 [1350 to 2560] ml in our GDT group) was administered intraoperatively. Challand et al found a trend of increased LOS in the GDT compared to a standard control in aerobically fit patients, raising the possibility that any benefit from optimised haemodynamics from GDT was offset by excessive fluid administration. In contrast, the GDT algorithm and perioperative fluid protocol utilised in this study avoided excessive fluid load, but allowed for individualised titration of fluid boluses.
Despite the achievement of haemodynamic goals and minimisation of fluid excess, GDT in this study did not confer any significant clinical advantage within an ERAS pathway. There was no difference in LOS or medically ready for discharge time. There was also no difference in patients experiencing minor and major outcomes. A lack of benefit from GDT relating to minor outcomes, such as hypotension or oliguria, suggests that fluid restriction is close to optimal fluid therapy and we would agree with Srinivasa and Brandstrup et al that GDT within an ERAS framework has no clear evidence of incremental benefit in terms of LOS and reducing overall complications 6, 7 .
One of the secondary outcomes was a finding of a significant reduction in the number of major complications favouring GDT (restrictive 9 versus GDT 1, P=0.007), but which represented a nonsignificant difference in the number of patients (restrictive 4 versus GDT 1, P=0.362). While there may be an association, this data alone is insufficient to draw a conclusion of benefit for GDT. Nevertheless, it is notable that while both groups did very well with a low rate of major complications, only one patient in the GDT group suffered a major complication. It is possible that the treatment effect of Doppler-guided fluid therapy is more modest and cannot be readily demonstrated over and above the improved outcomes associated with ERAS, including reduced LOS and fewer complications 2 . This study does not refute the benefit of the selective use of GDT in a higher-risk group where the benefits have been demonstrated in terms of reduction in major complications 8 . However, there are no studies to date which have identified a high-risk patient group within an ERAS program. Additional information may be provided by current trials such as the Restrictive Versus Liberal Fluid Therapy in Major Abdominal Surgery (RELIEF) study, which is a large multicentre randomised control trial of 2800 patients currently being undertaken that will look primarily at restrictive compared to liberal fluid therapy in a major abdominal surgery study 24 . It will also observe the effect of goal-directed therapy in a subgroup and will hopefully yield important infor mation from this high-risk group that includes patients over 70 years old and those who have major comorbidities. Similarly, higher-risk colorectal procedures such as rectal resections may be a better target for GDT.
This study has been deliberate in targeting patients suitable for an ERAS program, which constitute the bulk of elective colectomies, giving it greater generalisability within a colorectal unit. We have tailored the outcomes to include minor complications, such as significant hypotension, postoperative nausea and vomiting and gastrointestinal morbidity, which are more common and have the potential to delay recovery in otherwise well patients. The findings are specific to within an ERAS program that emphasises preoperative carbohydrate drinks and early oral postoperative fluid intakes (caution should be exercised extrapolating the results outside of such a program).
While we were unable to demonstrate a benefit in terms of LOS from GDT compared to restrictive fluid therapy, this study was not powered to detect difference in LOS <2 days. For example, if a oneday reduction existed, it could have been missed. Similarly, we cannot be sure about the absence of differences in major complications. Nevertheless, the findings in this study do not support earlier GDT studies that showed marked improvements in outcome, including a reduction in LOS and reduction in complication rate favouring GDT 17 . The lack of a significant treatment effect may reflect different perioperative practices between earlier studies and contemporary practice. Some major changes may include greater utilisation of laparoscopic surgery 25 , more limited surgical incisions, carbohydrate drink administration and early enteral fluid and feeding 2 .
The changes in perioperative practices can clearly be seen when comparing a mean LOS of 12 days for the control group by Noblett et al in 2006 with a median LOS of six (four to nine) days in this study 26 .
Subgroup analysis of patients with stomas (compared to patients with no stoma) was not performed, as there was only a modest trend of increased LOS which was not statistically significant. This makes it unlikely that there would be a difference between restrictive fluid therapy and GDT in stomal patients alone. Similarly, there was no apparent significant difference in LOS among patients with inflammatory bowel disease.
We found that GDT was associated with an increased SV after fluid optimisation with the Doppler monitor. However, this did not result in a significant difference in the LOS and we did not observe a difference in the number of patients experiencing minor or major complications. This suggests that increasing global oxygen delivery with fluid therapy alone in this group of elective colorectal surgery patients was not beneficial. Future work should focus on GDT in higher-risk patients or in higher-risk surgery.
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